In vitro studies further highlight the ability of quercetin to decrease cytokine levels, such as IL-1β and TNF-α, and modulate matrix metalloproteinases (MMPs) in peripheral blood mononuclear cells from MS patients [253]. The gene discussed is IL1B; the disease is myeloid sarcoma.